Avilés, A <br/><br/>
GM-CSF instead of hematological support during high-dose chemotherapy for refractory malignant lymphoma.  [electronic resource] 

 -  Leukemia & lymphoma  Apr 1995 
 - 327-30 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1042-8194 
<br/><br/><label>Standard No.: </label>10.3109/10428199509056839  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Agranulocytosis--chemically induced<br/>Bone Marrow Transplantation<br/>Combined Modality Therapy<br/>Cyclophosphamide--adverse effects<br/>Dose-Response Relationship, Drug<br/>Female<br/>Granulocyte-Macrophage Colony-Stimulating Factor--adverse effects<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Infusions, Intravenous<br/>Lymphoma, Non-Hodgkin--blood<br/>Male<br/>Middle Aged<br/>Pilot Projects<br/>Platelet Transfusion<br/>Prognosis